Newsroom

Home › Resources › Newsroom

The Pulse by NABP Product Verification Service Protects Patients

Since the Drug Supply Chain Security Act (DSCSA) regulations for pharmaceutical trading partners have been restructuring supply chain ecosystems in the pharmacy industry, we have been building and testing our DSCSA compliance solution, Pulse by NABP™. This inclusive, accessible, and secure digital platform will simplify the process of achieving compliance for regulators and trading partners.

Jenni Wai, MBA, RPh, Chief Pharmacist of the Ohio Board of Pharmacy and John Kirtley, PharmD, Executive Director of the Arkansas State Board of Pharmacy | October 1, 2025

A New Horizon for Patient Safety: Reflections on the Operation African Star 2 Pilot

Josh Bolin, Senior Vice President, Pulse by NABP | August 11, 2025

Driving Forward with Pharmaceutical Traceability: Anticipating the July Pilot Workshops in Kenya and Uganda

Josh Bolin, Senior Vice President, Pulse by NABP | June 30, 2025

Filter by

Reflections on a Landmark Webinar: Strengthening Supply Chains and Protecting Patients

Josh Bolin, Senior Vice President, Pulse by NABP | June 10, 2025

Serial Number Decommissioning - Part 2

March 3, 2025

Serial Number Decommissioning Pilot Report

November 7, 2024

FDA’s DSCSA Exemption for Connected Trading Partners

Josh Bolin, Associate Executive Director, Government Affairs and Innovation | October 23, 2024

NABP Announces Walgreens Joining Pulse Platform

September 10, 2024

FDA’s Small Dispenser DSCSA Exemption

Josh Bolin, Associate Executive Director, Government Affairs and Innovation | July 19, 2024

Veteran’s Health Administration Joins Pulse by NABP

January 23, 2024

What Trading Partners Need to Know Before the DSCSA Deadline

Brian Waldman, Esq, Partner, ArentFox Schiff LLP and Tish Pahl, Esq, Principal, Olsson Frank Weeda Terman Matz PC | November 8, 2023

NABP Launches Pulse Interoperable Partner Program to Accelerate Interoperability in Drug Supply Chain

August 29, 2023